Pulse Journal Club Trending Explore Questions Researchers

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026Privacy Policy

Home Explore Journal Club Trending

⌘+K

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer | Synapse

January 3, 2008

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

Capecitabine and oxaliplatin are as effective as fluorouracil and cisplatin, respectively, in patients with previously untreated esophagogastric cancer. (Current Controlled Trials number, ISRCTN51678883 controlled-trials.com.).

Mark Helpful

Bookmark

Relay

Mark Helpful

Bookmark

Relay

Cite This Study

Cunningham et al. (Thu,) studied this question.

synapsesocial.com/papers/69d56c0d75589c71d767cafa https://doi.org/https://doi.org/10.1056/nejmoa073149

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF2005 · 145 citations
2Patient preferences for oral versus intravenous palliative chemotherapy.1997 · 920 citations
3New Guidelines to Evaluate the Response to Treatment in Solid Tumors2000 · 15,715 citations
4Global Cancer Statistics, 20022005 · 18,387 citations
5Global cancer statistics2011 · 55,039 citations